Clinical Trial Update: Statins for Prevention of Contrast Induced Nephropathy [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating statins for prevention of contrast-induced nephropathy. The study status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Contrast-induced Nephropathy

Drugs mentioned

• Statins

Snippet

Sponsor: Ospedale Misericordia e Dolce | Conditions: Contrast Induced Nephropathy | Phase 4 | Status: COMPLETED